NCT07442851

Brief Summary

To goal of this study is to pilot the SickleFit exercise and nutrition intervention in adults with sickle cell disease in a randomized control trial

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
17mo left

Started Apr 2026

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress19%
Apr 2026Jan 2028

First Submitted

Initial submission to the registry

February 20, 2026

Completed
10 days until next milestone

First Posted

Study publicly available on registry

March 2, 2026

Completed
1 month until next milestone

Study Start

First participant enrolled

April 8, 2026

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2028

Last Updated

May 7, 2026

Status Verified

May 1, 2026

Enrollment Period

1.7 years

First QC Date

February 20, 2026

Last Update Submit

May 4, 2026

Conditions

Keywords

sickle cell diseaseexercisenutritionagingfunctional impairment

Outcome Measures

Primary Outcomes (5)

  • Feasibility of Randomization

    Feasibility of randomization (proportion of participants randomized out of those approached)

    From enrollment to the last paticipants randomized over a 2 year period

  • Safety/Adverse Events

    number of life-threatening adverse events

    adverse events will be measured for both arms up to 6 months

  • Acceptability

    Proportion of participants reporting satisfaction with the program

    From enrollment to after completion of the SickleFit Program over 6 months since we will also measure acceptability for control group

  • Retention in the program

    retention (proportion of the SickleFit and control groups completing follow up assessment)

    From the baseline Sickle Cell Disease Functional Assessment to the post-SCD-FA. Over a 30 week period since post assessments will be completed within 3 months of completion of the SickleFit program or control period.

  • Adherence

    Adherence (proportion attending ≥ 50% of classes) in the SickleFit arm

    From the start of the first SickleFit session to the end of the SickleFit program at 12 weeks

Other Outcomes (1)

  • Performance on the Sickle Cell Disease Functional Assessment (SCD-FA)

    From baseline assessment to completion of the post-assessment within 6 months

Study Arms (2)

SickleFit arm

EXPERIMENTAL

Participants in SickleFit arm will complete the Sickle Cell Disease Functional Assessment before and after 12 weeks of SickleFit exeercise+Nutrition intervention.

Behavioral: SickleFit Exercise plus Nutrition

Control Arm

NO INTERVENTION

Participants in the control arm will be on a wait list for SickleFit and will continue to receive usual care during that 12-week period. They will complete the Sickle Cell Disease Functional Assessment at baseline and after 12 weeks on the wait list. After their post-assessment, they will have the option to complete 12 weeks of SickleFit exercise+Nutrition intervention.

Interventions

SickleFit personalized exercise plus dietitian-facilitated nutrition intervention

SickleFit arm

Eligibility Criteria

Age35 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Laboratory-confirmed diagnosis of sickle cell disease (any genotype)
  • Understand and speak English by self-report
  • Age ≥ 35 years old

You may not qualify if:

  • Oxygen dependence
  • Unstable cardiac disease
  • Wheelchair-bound
  • Diagnosed with severe cognitive impairment based on ICD-10 codes or reported by their outpatient provider
  • Unable to self-consent
  • Severe uncorrected visual or auditory impairment
  • Pregnant
  • Successfully treated with hematopoietic stem cell transplantation or gene therapy for sickle cell disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Duke University

Durham, North Carolina, 27710, United States

RECRUITING

Related Publications (1)

  • Charity I Oyedeji, Teagan Callaway, Rania Mohamed, Reena Ravi, Richard Faldowski, Corey Vessels, Miriam C Morey, John J Strouse; The Sicklefit Exercise Program for Older Adults with Sickle Cell Disease: Feasibility, Acceptability, and Safety. Blood 2024; 144 (Supplement 1): 604. doi: https://doi.org/10.1182/blood-2024-212100

    BACKGROUND

MeSH Terms

Conditions

Anemia, Sickle CellMotor Activity

Interventions

Nutritional Status

Condition Hierarchy (Ancestors)

Anemia, Hemolytic, CongenitalAnemia, HemolyticAnemiaHematologic DiseasesHemic and Lymphatic DiseasesHemoglobinopathiesGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesBehavior

Intervention Hierarchy (Ancestors)

Nutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological PhenomenaHealth StatusDemographyPopulation Characteristics

Study Officials

  • Charity I Oyedeji, MD

    Duke University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Teagan Callaway

CONTACT

Rania Mohamed

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: We will conduct a 12-week randomized control trial of a combined SickleFit exercise plus dietitian-led nutrition education intervention to be delivered virtual via Zoom in 40 adults (age ≥ 35) with sickle cell disease. There will be 20 participants in the SickleFit arm and 20 participants in the control arm. Randomization will be done 1:1.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 20, 2026

First Posted

March 2, 2026

Study Start

April 8, 2026

Primary Completion (Estimated)

January 1, 2028

Study Completion (Estimated)

January 1, 2028

Last Updated

May 7, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will not share

Locations